| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.97e-06 | 16 | 36 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 7.00e-06 | 21 | 36 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 1.89e-05 | 4 | 36 | 2 | GO:0030229 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.80e-04 | 85 | 36 | 3 | GO:0038024 | |
| Domain | LDLR_class-A_CS | 9.00e-07 | 40 | 35 | 4 | IPR023415 | |
| Domain | Ldl_recept_a | 1.46e-06 | 45 | 35 | 4 | PF00057 | |
| Domain | - | 1.59e-06 | 46 | 35 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.90e-06 | 48 | 35 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.06e-06 | 49 | 35 | 4 | IPR002172 | |
| Domain | LDLa | 2.06e-06 | 49 | 35 | 4 | SM00192 | |
| Domain | LDLRA_2 | 2.06e-06 | 49 | 35 | 4 | PS50068 | |
| Domain | Ldl_recept_b | 2.16e-06 | 14 | 35 | 3 | PF00058 | |
| Domain | LDLRB | 2.16e-06 | 14 | 35 | 3 | PS51120 | |
| Domain | LY | 2.70e-06 | 15 | 35 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.70e-06 | 15 | 35 | 3 | IPR000033 | |
| Domain | - | 5.26e-05 | 39 | 35 | 3 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 8.66e-05 | 46 | 35 | 3 | IPR011042 | |
| Domain | IG_FLMN | 1.52e-04 | 10 | 35 | 2 | SM00557 | |
| Domain | Filamin | 1.86e-04 | 11 | 35 | 2 | PF00630 | |
| Domain | Filamin/ABP280_rpt | 1.86e-04 | 11 | 35 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.86e-04 | 11 | 35 | 2 | IPR017868 | |
| Domain | FILAMIN_REPEAT | 1.86e-04 | 11 | 35 | 2 | PS50194 | |
| Domain | Zinc_finger_PHD-type_CS | 2.43e-04 | 65 | 35 | 3 | IPR019786 | |
| Domain | EGF_CA | 5.55e-04 | 86 | 35 | 3 | PF07645 | |
| Domain | ZF_PHD_1 | 7.64e-04 | 96 | 35 | 3 | PS01359 | |
| Domain | EGF_Ca-bd_CS | 7.88e-04 | 97 | 35 | 3 | IPR018097 | |
| Domain | EGF_CA | 8.36e-04 | 99 | 35 | 3 | PS01187 | |
| Domain | Actinin_actin-bd_CS | 8.42e-04 | 23 | 35 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 8.42e-04 | 23 | 35 | 2 | PS00020 | |
| Domain | ACTININ_1 | 8.42e-04 | 23 | 35 | 2 | PS00019 | |
| Domain | ASX_HYDROXYL | 8.61e-04 | 100 | 35 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.02e-03 | 106 | 35 | 3 | IPR000152 | |
| Domain | EGF_CA | 1.53e-03 | 122 | 35 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.60e-03 | 124 | 35 | 3 | IPR001881 | |
| Domain | Znf_FYVE_PHD | 2.60e-03 | 147 | 35 | 3 | IPR011011 | |
| Domain | Growth_fac_rcpt_ | 3.08e-03 | 156 | 35 | 3 | IPR009030 | |
| Domain | CH | 6.59e-03 | 65 | 35 | 2 | SM00033 | |
| Domain | CH | 7.61e-03 | 70 | 35 | 2 | PF00307 | |
| Domain | - | 7.82e-03 | 71 | 35 | 2 | 1.10.418.10 | |
| Domain | CH | 8.25e-03 | 73 | 35 | 2 | PS50021 | |
| Domain | PHD | 8.69e-03 | 75 | 35 | 2 | PF00628 | |
| Domain | CH-domain | 8.69e-03 | 75 | 35 | 2 | IPR001715 | |
| Domain | EGF_3 | 9.57e-03 | 235 | 35 | 3 | PS50026 | |
| Domain | EGF | 9.57e-03 | 235 | 35 | 3 | SM00181 | |
| Domain | Znf_PHD-finger | 9.60e-03 | 79 | 35 | 2 | IPR019787 | |
| Domain | EGF-like_dom | 1.12e-02 | 249 | 35 | 3 | IPR000742 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 1.15e-04 | 11 | 21 | 2 | M48099 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 3.19e-04 | 18 | 21 | 2 | MM15123 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 3.19e-04 | 18 | 21 | 2 | M840 | |
| Pubmed | RSBN1 GPATCH4 CEP295 CLSPN SIPA1L2 LDLR ANKRD54 CHD5 BRD9 SCAPER | 1.32e-07 | 1116 | 36 | 10 | 31753913 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 7689010 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8662771 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 10679933 | ||
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 1.04e-06 | 2 | 36 | 2 | 24469451 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.34e-06 | 21 | 36 | 3 | 21337463 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 11252955 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12704190 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 8626535 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 20223219 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 11038172 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 11102480 | ||
| Pubmed | Filamin A negatively regulates the transcriptional activity of p73alpha in the cytoplasm. | 3.12e-06 | 3 | 36 | 2 | 17825253 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12393796 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 19948739 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9412467 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 11153914 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 27522265 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 20554076 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 6.24e-06 | 4 | 36 | 2 | 22802962 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 10571240 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 22109552 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 8.12e-06 | 724 | 36 | 7 | 36232890 | |
| Pubmed | PCSK9 binds to multiple receptors and can be functionally inhibited by an EGF-A peptide. | 1.04e-05 | 5 | 36 | 2 | 18675252 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 19366992 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 12006559 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 17360453 | ||
| Pubmed | 1.21e-05 | 1442 | 36 | 9 | 35575683 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.39e-05 | 1105 | 36 | 8 | 35748872 | |
| Pubmed | PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain. | 1.56e-05 | 6 | 36 | 2 | 20453200 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 9006895 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 12679033 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 26929074 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 16076904 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 12169628 | ||
| Pubmed | 2.87e-05 | 57 | 36 | 3 | 21555454 | ||
| Pubmed | MEKK4 signaling regulates filamin expression and neuronal migration. | 2.91e-05 | 8 | 36 | 2 | 17145501 | |
| Pubmed | HSPB7 prevents cardiac conduction system defect through maintaining intercalated disc integrity. | 2.91e-05 | 8 | 36 | 2 | 28827800 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 10380922 | ||
| Pubmed | Comparative mapping of the actin-binding protein 280 genes in human and mouse. | 3.73e-05 | 9 | 36 | 2 | 8088838 | |
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 20005821 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 11807098 | ||
| Pubmed | 5.13e-05 | 1327 | 36 | 8 | 32694731 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 36579465 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 9.41e-05 | 14 | 36 | 2 | 17389516 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 9.61e-05 | 232 | 36 | 4 | 25515538 | |
| Pubmed | 9.75e-05 | 733 | 36 | 6 | 34672954 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 1.58e-04 | 18 | 36 | 2 | 12119179 | |
| Pubmed | 1.58e-04 | 18 | 36 | 2 | 10827173 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.58e-04 | 101 | 36 | 3 | 23382219 | |
| Pubmed | Asb2α-Filamin A Axis Is Essential for Actin Cytoskeleton Remodeling During Heart Development. | 1.76e-04 | 19 | 36 | 2 | 29374072 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.00e-04 | 1201 | 36 | 7 | 35696571 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 2.28e-04 | 857 | 36 | 6 | 25609649 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.34e-04 | 861 | 36 | 6 | 36931259 | |
| Pubmed | 2.38e-04 | 22 | 36 | 2 | 18487259 | ||
| Pubmed | 2.60e-04 | 23 | 36 | 2 | 8464923 | ||
| Pubmed | 2.76e-04 | 122 | 36 | 3 | 30773093 | ||
| Pubmed | 3.40e-04 | 591 | 36 | 5 | 15231748 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.87e-04 | 608 | 36 | 5 | 36089195 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 4.04e-04 | 954 | 36 | 6 | 36373674 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 4.77e-04 | 147 | 36 | 3 | 28977470 | |
| Pubmed | Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study. | 5.07e-04 | 32 | 36 | 2 | 25189868 | |
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 5.39e-04 | 33 | 36 | 2 | 22357600 | |
| Pubmed | 5.39e-04 | 33 | 36 | 2 | 32140074 | ||
| Pubmed | 5.43e-04 | 655 | 36 | 5 | 35819319 | ||
| Pubmed | 5.71e-04 | 1429 | 36 | 7 | 35140242 | ||
| Pubmed | USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation. | 6.78e-04 | 37 | 36 | 2 | 32133736 | |
| Pubmed | 6.82e-04 | 689 | 36 | 5 | 36543142 | ||
| Pubmed | 8.10e-04 | 407 | 36 | 4 | 12693553 | ||
| Pubmed | 8.18e-04 | 177 | 36 | 3 | 26206133 | ||
| Pubmed | Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. | 8.33e-04 | 41 | 36 | 2 | 18157088 | |
| Pubmed | 8.57e-04 | 725 | 36 | 5 | 27025967 | ||
| Pubmed | RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma. | 9.00e-04 | 183 | 36 | 3 | 28186131 | |
| Pubmed | 9.18e-04 | 421 | 36 | 4 | 36976175 | ||
| Pubmed | STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency. | 1.03e-03 | 192 | 36 | 3 | 32176739 | |
| GeneFamily | Low density lipoprotein receptors | 6.62e-07 | 13 | 25 | 3 | 634 | |
| GeneFamily | PHD finger proteins | 2.53e-04 | 90 | 25 | 3 | 88 | |
| Coexpression | SHEPARD_CRASH_AND_BURN_MUTANT_DN | 6.12e-06 | 191 | 36 | 5 | M2148 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 2.39e-05 | 429 | 36 | 6 | M29 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.72e-05 | 192 | 36 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | RSBN1 SPRED1 GPATCH4 CEP295 GRIK2 CLIC5 CLSPN USP1 PHF3 ICE2 LRP8 | 1.88e-05 | 1459 | 36 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 3.00e-05 | 989 | 36 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.90e-05 | 271 | 36 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.24e-04 | 291 | 36 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 1.91e-04 | 1257 | 36 | 9 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.16e-07 | 197 | 36 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 5.56e-07 | 200 | 36 | 5 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 179 | 36 | 4 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.32e-05 | 180 | 36 | 4 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-05 | 183 | 36 | 4 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 1.44e-05 | 184 | 36 | 4 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-05 | 185 | 36 | 4 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 186 | 36 | 4 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 186 | 36 | 4 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 187 | 36 | 4 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-05 | 187 | 36 | 4 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.57e-05 | 188 | 36 | 4 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.63e-05 | 190 | 36 | 4 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 192 | 36 | 4 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-05 | 193 | 36 | 4 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-05 | 193 | 36 | 4 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-05 | 193 | 36 | 4 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-05 | 193 | 36 | 4 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 193 | 36 | 4 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-05 | 193 | 36 | 4 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-05 | 193 | 36 | 4 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-05 | 193 | 36 | 4 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-05 | 194 | 36 | 4 | 0cd4363627acd419e00d6d32f6dce10430aa6487 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-05 | 194 | 36 | 4 | a58841b34efe673671a9a059238e044a7254b279 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 194 | 36 | 4 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 196 | 36 | 4 | 22fcfb713f402ebbd43b2822f0fd919cdbfba6e4 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.84e-05 | 196 | 36 | 4 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.96e-05 | 199 | 36 | 4 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.00e-05 | 200 | 36 | 4 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.00e-05 | 200 | 36 | 4 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 2.00e-05 | 200 | 36 | 4 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.00e-05 | 200 | 36 | 4 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.00e-05 | 200 | 36 | 4 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.00e-05 | 200 | 36 | 4 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.00e-05 | 200 | 36 | 4 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.49e-04 | 152 | 36 | 3 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 2.68e-04 | 156 | 36 | 3 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-04 | 158 | 36 | 3 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-04 | 159 | 36 | 3 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-04 | 159 | 36 | 3 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.84e-04 | 159 | 36 | 3 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-04 | 159 | 36 | 3 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 160 | 36 | 3 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.16e-04 | 165 | 36 | 3 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 167 | 36 | 3 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 3.34e-04 | 168 | 36 | 3 | 8ade4d098aeecda2d80c1cad1cebe9a063eae948 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.34e-04 | 168 | 36 | 3 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 168 | 36 | 3 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 168 | 36 | 3 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 168 | 36 | 3 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 3.39e-04 | 169 | 36 | 3 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 170 | 36 | 3 | 60bbd738c12e64e483485586c30057304884f5a6 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-04 | 170 | 36 | 3 | f664c7559e383b37845c123e41a3be316d869ba0 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-04 | 170 | 36 | 3 | 0272eb1487c2545d4aa06f5d1cd77f823e1441e9 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 3.51e-04 | 171 | 36 | 3 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-NK_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.57e-04 | 172 | 36 | 3 | a126dacd94939851de1403d30f0b63eaad48bfa1 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 173 | 36 | 3 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 173 | 36 | 3 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 173 | 36 | 3 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.63e-04 | 173 | 36 | 3 | a55f310c533432e9e26e400026a5b47245152976 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 3.63e-04 | 173 | 36 | 3 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.63e-04 | 173 | 36 | 3 | 9c7386bf0a899882c733f0b4921a96afde032a7d | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 173 | 36 | 3 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.70e-04 | 174 | 36 | 3 | 4a1b67ce5ea353b3f81f59fa57da07668146afca | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-04 | 174 | 36 | 3 | 66555c610251ea04f968c258e312d720c18e7cde | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.70e-04 | 174 | 36 | 3 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | Club-club-15|World / Class top | 3.76e-04 | 175 | 36 | 3 | ca9d012f520f697c7450ec6958a015e20538a6a8 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.76e-04 | 175 | 36 | 3 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 3.76e-04 | 175 | 36 | 3 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 3.76e-04 | 175 | 36 | 3 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.82e-04 | 176 | 36 | 3 | 04dad262929581872e5bbc66cd8182c963e7e52f | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 176 | 36 | 3 | 606704098bfdf8bfef740a3544a372fae1e75969 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 176 | 36 | 3 | acb9e29773030f6452a069f8f7e53eab68ab7bd3 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.88e-04 | 177 | 36 | 3 | cbedac0bddb8fc330a464815c905928c553b0fc0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 177 | 36 | 3 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.95e-04 | 178 | 36 | 3 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-04 | 178 | 36 | 3 | c661246269ce26c4fc62e12f86c5f90a2dcfdce0 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.95e-04 | 178 | 36 | 3 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-04 | 178 | 36 | 3 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-04 | 178 | 36 | 3 | 6bef4ef48f649c6e38ae732bc08e6d7814db588b | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.95e-04 | 178 | 36 | 3 | 04bfecf5ea5d85c843e48d08718b5d69e7bf834e | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-04 | 178 | 36 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-04 | 178 | 36 | 3 | e5e5f5b4a27e120a1076b1cb250fa25d0c336956 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.95e-04 | 178 | 36 | 3 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-04 | 179 | 36 | 3 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.01e-04 | 179 | 36 | 3 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 4.08e-04 | 180 | 36 | 3 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.08e-04 | 180 | 36 | 3 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | CV-Healthy-2|CV / Virus stimulation, Condition and Cluster | 4.08e-04 | 180 | 36 | 3 | e182e5c495dd82d4fcbf1a920086c70b064801f3 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 180 | 36 | 3 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 180 | 36 | 3 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.15e-04 | 181 | 36 | 3 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 181 | 36 | 3 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 181 | 36 | 3 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 181 | 36 | 3 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 181 | 36 | 3 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 4.15e-04 | 181 | 36 | 3 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.21e-04 | 182 | 36 | 3 | cc6f9d606a4f8717dc44928ceec2a257636043fd | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.21e-04 | 182 | 36 | 3 | e6968e0bd9cef92052d04ac54e2dd746b37623f6 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell-plasma_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.28e-04 | 183 | 36 | 3 | 0f6799e4f058bed546fe5759502430f4a19635da | |
| Drug | Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; HL60; HT_HG-U133A | 5.75e-07 | 195 | 36 | 6 | 1267_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 9.03e-06 | 180 | 36 | 5 | 4541_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; HL60; HT_HG-U133A | 1.47e-05 | 199 | 36 | 5 | 2550_DN | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 4.10e-06 | 3 | 35 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 4.10e-06 | 3 | 35 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | executive function measurement | 7.75e-05 | 376 | 35 | 5 | EFO_0009332 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.74e-04 | 447 | 35 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | coronary artery calcification | 1.80e-04 | 450 | 35 | 5 | EFO_0004723 | |
| Disease | diet measurement | 1.98e-04 | 1049 | 35 | 7 | EFO_0008111 | |
| Disease | Dyslipidemias | 3.71e-04 | 24 | 35 | 2 | C0242339 | |
| Disease | unipolar depression, neuroticism measurement | 3.71e-04 | 24 | 35 | 2 | EFO_0003761, EFO_0007660 | |
| Disease | Dyslipoproteinemias | 3.71e-04 | 24 | 35 | 2 | C0598784 | |
| Disease | arteriosclerosis (is_implicated_in) | 6.22e-04 | 31 | 35 | 2 | DOID:2349 (is_implicated_in) | |
| Disease | pack-years measurement, systolic blood pressure | 7.49e-04 | 34 | 35 | 2 | EFO_0006335, EFO_0006526 | |
| Disease | oral microbiome measurement | 1.14e-03 | 42 | 35 | 2 | EFO_0801229 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDGADPCAADDKGRT | 131 | Q6NXT1 | |
| DDNDDGCLKEPKSSG | 121 | Q8TDI0 | |
| CDTEGEADDFDPGKK | 101 | Q9H8M2 | |
| GNKKLDEGEECDCGP | 406 | Q9H2U9 | |
| PEEIDANTCGEDKGS | 316 | Q9NZA1 | |
| EKDCEDGSDEKGCNG | 1076 | Q9NZR2 | |
| LCNGKKDCPDGSDEG | 1156 | Q9NZR2 | |
| SGNDVTDIADDGCPK | 21 | P00738 | |
| TSGGEKPNKDLESCS | 116 | Q5T3I0 | |
| PSQAKIECDDKGDGS | 611 | Q14315 | |
| DDQDSEKSKPAGSDG | 181 | Q1KMD3 | |
| KGLNGCDSPDPDADD | 91 | Q06413 | |
| GPRDADSDENDKGEK | 241 | Q14671 | |
| CENGADDDKLSKPVA | 601 | Q5T0Z8 | |
| GGPEECKNKDDQGFE | 476 | Q659A1 | |
| PSQAKIECDDKGDGS | 616 | P21333 | |
| KQDLDEDLLGCSPGD | 206 | Q6MZW2 | |
| DSNPEDSGEGKKESL | 406 | Q8IV38 | |
| GNGCPEEESKEASAL | 801 | Q13002 | |
| SEDKPLSCGTNSGKE | 461 | Q9C0D2 | |
| ESKDDDGKPKCQTGG | 36 | Q9BY12 | |
| GDRDCKDKSDEADCP | 281 | Q14114 | |
| QDCKSLADPGSSDDD | 871 | A8MW92 | |
| DGDPSSCGTDLKHKD | 201 | Q5VWQ0 | |
| DEGDGKSNDLVLSCP | 396 | Q9P2F8 | |
| CKGEDATDDQFESPK | 1556 | Q5T5P2 | |
| PEPDRKKSGNACDND | 496 | Q8IXF0 | |
| EESPNGSEGACEKEK | 301 | O94844 | |
| GKQPSKLDEDDSCSL | 751 | Q9HAW4 | |
| GAPKKSEDCSGEGKD | 201 | Q96BF3 | |
| GCPESKNEAEGADDL | 126 | Q7Z699 | |
| SKGNPECDGKEDCSD | 581 | Q9Y5Y6 | |
| EDGLDSKHKCNNPGE | 231 | Q92576 | |
| DICDKVGSTPNGAKD | 31 | O75886 | |
| KDQPPGSDSDEDCQK | 476 | Q9UI33 | |
| SKENECDPEEDLGKC | 371 | O94782 | |
| CDGGPDCKDKSDEEN | 216 | P01130 |